Position history for Hudson Bay Capital Management LP's holdings in NEUROCRINE BIOSCIENCES INC
Hudson Bay Capital Management LP holds 395,850 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $52.1M as of 2026-Q1. The position was increased (+29.8% shares). NBIX represents 0.2% of Hudson Bay Capital Management LP's portfolio.
Current Value
$52.1M
Current Shares
395,850
Total Value Change
+$46M
Total Shares Change
+350,850
Other major holders of NBIX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 395,850 |
+29.8% |
| $52.1M |
| 0.2% |
| $131.14 |
44 |
| 2025-Q4 | Increased | 305,000 | +652.9% | $43.3M | 0.1% | $140.95 | 56 |
| 2025-Q3 | Decreased | 40,510 | -47.8% | $5.7M | 0.0% | $140.27 | 0 |
| 2025-Q2 | Decreased | 77,593 | -48.4% | $9.8M | 0.0% | $125.42 | 0 |
| 2025-Q1 | Increased | 150,380 | +395.6% | $16.6M | 0.1% | $113.16 | 46 |
| 2024-Q4 | Decreased | 30,342 | -24.1% | $4.1M | 0.0% | $137.06 | 0 |
| 2024-Q3 | Decreased | 40,000 | -11.1% | $4.6M | 0.0% | $115.06 | 0 |
| 2024-Q2 | Increased | 45,000 | +50.0% | $6.2M | 0.0% | $137.67 | 38 |